Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tenet Healthcare (THC) Tops Q2 EPS by $1.97
August 3, 2020 4:19 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $1.26, $1.97 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $3.65 billion versus the consensus estimate of $3.76 billion.
Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations of $24 million, or $0.23 per diluted share, in 2Q19Consolidated Adjusted EBITDA of $732 million in 2Q20 versus $669 million in 2Q19Federal stimulus support received was critical in addressing pandemic challenges, allowing uninterrupted response across our care facilitiesExperienced pronounced volatility in... More